Ophthalmologic Drug Guide (Paperback, 2nd ed. 2011)

Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have become increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.). There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry-eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.

General

Imprint:	Springer-Verlag New York
Country of origin:	United States
Release date:	December 2010
First published:	2011
Authors:	Douglas J. Rhee • Kathryn A Colby • Lucia Sobrin • Christopher J. Rapuano
Dimensions:	203 x 127 x 8mm (L x W x T)
Format:	Paperback
Pages:	138
Edition:	2nd ed. 2011
ISBN-13:	978-1-4419-7620-8
Categories:	Books > Medicine > Clinical & internal medicine > Ophthalmology Books > Medicine > Other branches of medicine > Pharmacology > General Promotions
LSN:	1-4419-7620-5
Barcode:	9781441976208

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!